Verified earnings results
Aytu BioPharma Q4 2026 Earnings Results
Direct answer
Aytu BioPharma reported Q4 2026 results on September 22, 2026.
Revenue was 16,110,000. EPS beat the estimate by 99.7%.
The result is verified against Verified earnings source.
Verified earnings source
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- September 22, 2026
- Reported timing
- After the US market closes
- EPS estimate
- -0.3315
- Reported EPS
- -0.001
- Revenue
- 16,110,000
- EPS surprise
- EPS beat the estimate by 99.7%.
Explore related company data
Read the frequently asked questions.
When did Aytu BioPharma report Q4 2026 earnings?
Aytu BioPharma reported on September 22, 2026. The reported timing was after the us market closes.
What is the available EPS estimate for Aytu BioPharma?
The verified record provides an EPS estimate of -0.3315.
Has Aytu BioPharma reported the Q4 2026 result?
Revenue was 16,110,000. EPS beat the estimate by 99.7%.
Which source supports this Aytu BioPharma earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.